iPath Pure Beta Lead ETN
LEDD
LEDD was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $17K invested in iPath Pure Beta Lead ETN in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
183% more capital invested
Capital invested by funds: $6K → $17K (+$11K)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$12.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
1
UBS
Zurich,
Switzerland
| $12K | +$12.1K | +319 | New |
|
2
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
LEDD Hedge Fund Activity: Q1 2014 in Review
2 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Lead ETN (LEDD) for Q1 2014, worth a combined $17K — up 183% from $6K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LEDD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS, opening a new position worth an estimated $12.1K.
- 2 institutional investors held iPath Pure Beta Lead ETN (LEDD) as of Q1 2014, up from 1 in Q4 2013.
- Funds reported $17K of iPath Pure Beta Lead ETN stock for Q1 2014, up 183% quarter-over-quarter.
- 1 fund opened new iPath Pure Beta Lead ETN positions in Q1 2014 and 0 closed out, a net change of +1 holder.
- The largest iPath Pure Beta Lead ETN buyer in Q1 2014 was UBS, an estimated $12.1K added.
Based on aggregated 13F filings for Q1 2014.